NFE2L2 and chronic obstructive pulmonary disease: It will be important to test inhalable formulation, which may be more efficacious than oral dosing, and other Nrf2 activators for COPD because a therapy targeting both oxidative stress and inflammation may be effective in modifying the disease such as COPD.